Newer concepts in antihypertensive drugs

U.S. Department of Health, Education, and Welfare National Health Survey, 1966, Hypertension and Hypertensive Heart Disease in Adults: United States 1960–1962, National Center for Health Statistics, U.S. Public Health Service Publication No. 1000 1973, National High Blood Pressure Education Program, National Heart and Lung Institute: Professional Education 1967, Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg, JAMA, 202, 1028, 10.1001/jama.1967.03130240070013 1970, Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg, JAMA, 213, 1143, 10.1001/jama.1970.03170330025003 Society of Actuaries, 1959, vol 1 Kannel, 1964, Risk factors in coronary heart disease. An evaluation of several serum lipids as predictors of coronary heart disease, Ann Intern Med, 61, 888, 10.7326/0003-4819-61-5-888 Kannel, 1971, Systolic versus diastolic blood pressure and risk of coronary heart disease, Am J Cardiol, 27, 335, 10.1016/0002-9149(71)90428-0 National Heart, Lung, and Blood Institute, 1976 Moser, 1977, Report of the Joint National Committee on Education, Evaluation, and Treatment of High Blood Pressure, JAMA, 237, 255, 10.1001/jama.1977.03270300059008 Meneely, 1961, Electrolytes in hypertension. The effects of sodium chloride, Med Clin North Am, 45, 271, 10.1016/S0025-7125(16)33891-3 Kempner, 1948, Treatment of hypertensive vascular disease with rice diet, Am J Med, 4, 545, 10.1016/0002-9343(48)90441-0 Dahl, 1958, Salt intake and salt needed, N Engl J Med, 258, 1152, 10.1056/NEJM195806052582305 Dahl, 1958, Salt intake and salt needed, N Engl J Med, 258, 1205, 10.1056/NEJM195806122582406 Dahl, 1958, The role of salt in the fall of blood pressure accompanying reduction in obesity, N Engl J Med, 258, 1186, 10.1056/NEJM195806122582402 Shapiro, 1960, Psychophysiologic mechanisms in hypertensive vascular disease, Ann Intern Med, 53, 64, 10.7326/0003-4819-53-1-64 Tarazi, 1970, Long-term thiazide therapy in hypertension. Evidence for persistent alteration of plasma volume and renin activity, Circulation, 41, 709, 10.1161/01.CIR.41.4.709 Frohlich, 1960, Hemodynamic alterations in hypertensive patients due to chlorothiazide, N Engl J Med, 262, 1261, 10.1056/NEJM196006232622502 Lohmöller, 1975, Mechanism of the immediate hemodynamic effects of chlorothiazide, Am Heart J, 89, 487, 10.1016/0002-8703(75)90156-8 Freis, 1960, Mechanism of the altered blood pressure responsiveness produced by chlorothiazide, J Clin Invest, 39, 1277, 10.1172/JCI104143 Gillenwater, 1962, Effect of chlorothiazide upon the response of the renal bed to vasoactive substance, Circ Res, 11, 283, 10.1161/01.RES.11.2.283 Frohlich, 1972, Altered vascular responsiveness. Initial hypotensive mechanism of thiazide diduretics, 140, 1190 DeCarvalho JGR, Dunn FG, Lohmöller G, et al: Hemodynamic correlates of prolonged thiazide therapy. Clin Pharmacol Ther (in press) Tobian, 1952, Tissue cations and water in arterial hypertension, Circulation, 5, 754, 10.1161/01.CIR.5.5.754 Dustan, 1972, Dependence of arterial pressure on intravascular volume in treated hypertensive patients, N Engl J Med, 286, 861, 10.1056/NEJM197204202861603 Nemati, 1977, Clinical study of ticrynafen. A new diuretic, antihypertensive, and uricosuric agent, JAMA, 237, 652, 10.1001/jama.1977.03270340038016 DeCarvalho JGR, Dunn FG, Chrysant SG, et al: Ticrynafen: A novel uricosuric antihypertensive natriuretic agent. Arch Intern Med (in press) Spark, 1968, Aldosteronism in hypertension. The spironolactone response test, Ann Intern Med, 69, 685, 10.7326/0003-4819-69-4-685 Bravo, 1973, Spironolactone as a nonspecific treatment for primary aldosteronism, Circulation, 48, 491, 10.1161/01.CIR.48.3.491 Gombos, 1966, Effects of MK-870 in normal subjects and hypertensive patients, N Engl J Med, 275, 1215, 10.1056/NEJM196612012752202 Frohlich, 1974, Inhibition of adrenergic function in the treatment of hypertension, Arch Intern Med, 133, 1033, 10.1001/archinte.1974.00320180151013 Frohlich, 1959, Clinical trial of guanethidine: A new type of antihypertensive agent, Med Ann DC, 28, 419 Chrysant, 1975, Systematic hemodynamic effects of bethanidine in essential hypertension, Circulation, 52, 137, 10.1161/01.CIR.52.1.137 Mitchell, 1967, Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride, JAMA, 202, 149, 10.1001/jama.1967.03130230099018 Kopin, 1968, False adrenergic transmitters, Ann Rev Pharmacol, 8, 377, 10.1146/annurev.pa.08.040168.002113 Heise, 1976, Hypotensive action by central alpha-adrenergic and dopaminergic receptor stimulation, 135 Finch, 1975, The central hypotensive action of clonidine and BAY1470 in cats and rats, Clin Sci Mol Med, 48, 2735 Onesti, 1969, Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155), Circulation, 32, 219, 10.1161/01.CIR.39.2.219 Hansson, 1973, Blood pressure crisis following withdrawal of clinidine (Catapres, Catapresan) with special reference to arterial and urinary cathecholamine levels, and suggestions for acute management, Am Heart J, 85, 605, 10.1016/0002-8703(73)90165-8 Goldberg, 1964, Monoamine oxidase inhibitors: Adverse reactions and possible mechanisms, JAMA, 190, 456, 10.1001/jama.1964.03070180054008 Crout, 1969, Anesthetic management of pheochromocytoma: The value of phenoxybenzamine and methoxy flurane, Anesthesiology, 30, 29, 10.1097/00000542-196901000-00015 Tarazi, 1970, Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases, Arch Intern Med, 125, 835, 10.1001/archinte.1970.00310050073008 Cohn, 1966, Relationship of plasma volume changes to resistance and capacitance vessel effect of sympathomimetic amines and angiotensin in man, Clin Sci, 30, 267 Frohlich, 1973, The use of beta-adrenergic blockade in hypertension, 333 Frohlich, 1969, Hyperdynamic beta-adrrenergic circulatory state: Increased beta receptor responsiveness, Arch Int Med, 123, 1, 10.1001/archinte.1969.00300110003001 Bühler, 1972, Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases, N Engl J Med, 287, 1209, 10.1056/NEJM197212142872401 Prichard, 1969, Treatment of hypertension with propranolol, Br Med J, 1, 7, 10.1136/bmj.1.5635.7 Zacharias, 1972, Propranolol in hypertension: A study of long-term therapy, 1964–1970, Am Heart J, 83, 755, 10.1016/0002-8703(72)90206-2 Tarazi, 1971, Plasma volume changes with long-term beta-adrenergic blockade, Am Heart J, 82, 770, 10.1016/0002-8703(71)90198-0 Dunn FG, DeCarvalho JGR, Frohlich ED: Hemodynamic, reflexive, and metabolic alterations induced by acute and chronic timolol therapy in hypertensive man. Circulation (in press) Gilmore, 1970, Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade, N Engl J Med, 282, 521, 10.1056/NEJM197003052821001 Jacest, 1972, Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade, N Engl J Med, 286, 617, 10.1056/NEJM197203232861201 Bhatia, 1973, A hemodynamic comparison of agents useful in hypertensive emergencies, Am Heart J, 85, 367, 10.1016/0002-8703(73)90371-2 Frohlich, 1976, Hypertension, 208 Brunner, 1973, Angiotensin II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood pressure, Lancet, 2, 1045, 10.1016/S0140-6736(73)92657-3 Streeten, 1975, Use of angiotensin II antagonist (saralasin) in recognition of “angiotensinogenic” hypertension, N Engl J Med, 292, 657, 10.1056/NEJM197503272921301 Gavras, 1976, Reciprocal relation between renin dependency and sodium dependency in essential hypertension, N Engl J Med, 295, 1278, 10.1056/NEJM197612022952302 Case, 1977, Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme, N Engl J Med, 296, 641, 10.1056/NEJM197703242961201 Dustan, 1976, Mechanisms controlling arterial pressure, 49